Patents by Inventor Stephen Thomas DURANT

Stephen Thomas DURANT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION OF ANTIBODY-DRUG CONJUGATE AND ATR INHIBITOR
    Publication number: 20230330243
    Abstract: A pharmaceutical product for administration of an anti HER2 antibody-drug conjugate in combination with an ATR inhibitor is provided. The anti-HER2 antibody-drug conjugate is an antibody-drug conjugate in which a drug linker represented by the following formula (wherein A represents the connecting position to an antibody) is conjugated to an anti-HER2 antibody via a thioether bond.
    Type: Application
    Filed: June 23, 2021
    Publication date: October 19, 2023
    Applicants: Daiichi Sankyo Company, Limited, AstraZeneca UK Limited
    Inventors: Jerome Thomas METTETAL, II, Stephen Thomas DURANT, Azadeh Cheraghchi Bashi ASTANEH, Alan Yin Kai LAU, Yann WALLEZ
  • COMBINATION OF ANTIBODY-DRUG CONJUGATE AND ATM INHIBITOR
    Publication number: 20230256110
    Abstract: A pharmaceutical product for administration of an anti HER2 antibody-drug conjugate in combination with an ATM inhibitor is provided. The anti-HER2 antibody-drug conjugate is an antibody-drug conjugate in which a drug linker represented by the following formula (wherein A represents the connecting position to an antibody) is conjugated to an anti-HER2 antibody via a thioether bond. Also provided is a therapeutic use and method wherein the antibody-drug conjugate and the ATM inhibitor are administered in combination to a subject: Formula (I).
    Type: Application
    Filed: June 23, 2021
    Publication date: August 17, 2023
    Applicants: AstraZeneca UK Limited, DAIICHI SANKYO COMPANY, LIMITED
    Inventors: Jerome Thomas METTETAL, II, Stephen Thomas DURANT, Azadeh Cheraghchi Bashi ASTANEH, Alan Yin Kai LAU, Yann WALLEZ